Starton Therapeutics, Inc
1 clinical trials · Sponsor
◉ Watch Starton Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM) (NCT06087653) | Starton Therapeutics, Inc | 2023-10-02 |
Track Starton Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.